• Publication & Reference: Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial. Gut. 2018.
  • DOI: 10.1136/gutjnl-2018-316794
  • Author(s): Major G, Bradshaw L, Boota N, Sprange K, Diggle M, Montgomery A, et al.
Research Theme | Gastrointestinal & Liver

Publication & Reference

Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial. Gut. 2018.

DOI

10.1136/gutjnl-2018-316794

Author(s)

Major G, Bradshaw L, Boota N, Sprange K, Diggle M, Montgomery A, et al.
Back to all publications

Website by Volute